SEC Form 4 · accession 0001140361-15-043351
IRADIMED CORP · IRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Serge Novovich
Director
Period of report
Dec 1, 2015
Accepted (ET)
Dec 2, 2015 · 1:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325618
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 1, 2015 | A | 1,000 | $1.48 | A | 101,983 | D | |
| Common Stock | Dec 1, 2015 | S | 1,000 | $31.1229 | D | 100,983 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.48 | Dec 1, 2015 | M | 1,000 | D | — | Dec 29, 2023 | Common Stock | 1,000 | 25,250 | D |
Explanation of responses
- F1This option, representing a right to purchase a total of 26,250 shares, was granted on 12/31/2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.